Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00342641 · ClinicalTrials.gov registry record

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
815,000
Enrollment target

NCT00342641: Completed study, sponsored by National Cancer Institute (NCI).

NCT00342641 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 815,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00342641 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
815,000 participants
Enrollment target

Study Summary

This study will investigate the possible relationship between infection with hepatitis C virus (HCV) and the development of certain hematologic cancers (Non-Hodgkin's lymphoma, Hodgkin's lymphoma, chronic lymphocytic leukemia, multiple myeloma) and thyroid cancer. HCV causes chronic hepatitis, cirrhosis, and liver cancer. It is transmitted primarily through injection drug use and transfusion of infected blood. Studies have shown that HCV may also be linked to hematologic cancers and thyroid cancer. This retrospective study will examine medical records from veterans with and without HCV infection who previously received treatment in the Veterans Administration medical system. Data collected on each subject will include the subject's race, sex, age and era of military service, presence of liver disease or thyroiditis at their baseline clinic visit, number of inpatient visits in the past 5 years and outpatient visits in the past year, and the presence of various specified cancers. The prevalence of cancer and other conditions among HCV-infected subjects and non-HCV infected subjects at baseline and the subsequent development of the cancers of interest in these two groups will be compared and analyzed for a possible causal relationship.

Trial Details

FieldValue
Enrollment Target 815,000 participants
Start Date 2005-06-08
Est. Completion 2011-12-13
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00342641 record still lists

NCT00342641 is an observational study that tracks outcomes without assigning an intervention. Its 815,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00342641 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00342641 about?

NCT00342641 is a clinical study titled "Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers". This study will investigate the possible relationship between infection with hepatitis C virus (HCV) and the development of certain hematologic cancers (Non-Hodgkin's lymphoma, Hodgkin's lymphoma, chronic lymphocytic leukemia, multiple myeloma) and thyroid cancer. HCV causes chronic hepatitis, cirrh...

What is the current status of trial NCT00342641?

This trial is currently completed. The enrollment target is 815,000 participants. The study started on 2005-06-08. Estimated completion is 2011-12-13.

Who is sponsoring clinical trial NCT00342641?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01073475 · 950,000 participants

    Maternal Newborn Health Registry

  • NCT06029933 · 960,000 participants

    Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

  • NCT05066763 · 1,000,000 participants

    Parkinson's Foundation Surveys

  • NCT07075341 · 1,000,000 participants

    Healthy Living BEYOND Weight Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00342641, the US trial registry maintained by the National Library of Medicine. NCT00342641 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.